Neurocrine Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 12.71 M | $1.78 B | -1.92% | 12.83% |
| VANGUARD GROUP INC | 11/07/2025 | 9.71 M | $1.36 B | -1.02% | 9.80% |
| DODGE & COX | 11/13/2025 | 5.56 M | $780.04 M | -0.18% | 5.61% |
| JPMORGAN CHASE & CO | 11/26/2025 | 4.73 M | $664.02 M | 10.99% | 4.78% |
| STATE STREET CORP | 11/14/2025 | 4.35 M | $610.16 M | -2.73% | 4.39% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 2.87 M | $402.43 M | -7.12% | 2.90% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 2.77 M | $388.44 M | 83.68% | 2.80% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 2.42 M | $339.48 M | 2.19% | 2.44% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.02 M | $283.50 M | 3.35% | 2.05% |
| MORGAN STANLEY | 11/14/2025 | 1.83 M | $256.47 M | 0.40% | 1.85% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 1.81 M | $254.34 M | -10.70% | 1.83% |
| BELLEVUE GROUP AG | 11/14/2025 | 1.76 M | $247.50 M | -3.13% | 1.78% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 10/20/2025 | 1.20 M | $168.84 M | 61.52% | 1.21% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2025 | 1.18 M | $166.26 M | 1.42% | 1.20% |
| RTW INVESTMENTS, LP | 11/14/2025 | 1.06 M | $149.09 M | 0.00% | 1.07% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 977.21 K | $137.18 M | -18.17% | 0.99% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/07/2025 | 948.03 K | $133.04 M | -8.16% | 0.96% |
| NORTHERN TRUST CORP | 11/14/2025 | 925.71 K | $129.95 M | -0.36% | 0.94% |
| BRAIDWELL LP | 11/14/2025 | 880.28 K | $123.57 M | -24.14% | 0.89% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 829.55 K | $116.45 M | 5.04% | 0.84% |
| CITADEL ADVISORS LLC | 11/14/2025 | 793.24 K | $111.35 M | -61.29% | 0.80% |
| UBS ASSET MANAGEMENT AMERICAS INC | 11/14/2025 | 765.24 K | $107.42 M | -44.85% | 0.77% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 761.40 K | $106.88 M | -2.21% | 0.77% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 710.12 K | $99.69 M | 3.75% | 0.72% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 704.25 K | $98.86 M | 7.85% | 0.71% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 697.02 K | $97.85 M | 3.11% | 0.70% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 693.45 K | $97.34 M | -0.38% | 0.70% |
| IEQ CAPITAL, LLC | 11/14/2025 | 692.60 K | $97.23 M | 20.88% | 0.70% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 634.97 K | $89.14 M | -9.74% | 0.64% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 618.13 K | $86.77 M | 5.77% | 0.62% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 614.58 K | $86.27 M | 38.65% | 0.62% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 609.61 K | $85.58 M | -11.12% | 0.62% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 595.17 K | $83.54 M | -23.31% | 0.60% |
| GW&K INVESTMENT MANAGEMENT, LLC | 11/12/2025 | 594.39 K | $83.44 M | -2.94% | 0.60% |
| THRIVENT FINANCIAL FOR LUTHERANS | 11/04/2025 | 571.79 K | $80.27 M | -27.37% | 0.58% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 566.94 K | $79.59 M | -28.37% | 0.57% |
| SWEDBANK AB | 10/15/2025 | 547.33 K | $76.83 M | 8.70% | 0.55% |
| JENNISON ASSOCIATES LLC | 10/30/2025 | 519.95 K | $72.99 M | -8.92% | 0.53% |
| PRIMECAP MANAGEMENT CO/CA/ | 11/12/2025 | 512.26 K | $71.91 M | -2.25% | 0.52% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2025 | 501.49 K | $70.40 M | 94.73% | 0.51% |
| FIERA CAPITAL CORP | 11/07/2025 | 479.68 K | $67.34 M | -2.23% | 0.48% |
| BROWN ADVISORY INC | 11/14/2025 | 468.55 K | $65.77 M | -21.81% | 0.47% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 450.80 K | $63.28 M | 9.96% | 0.46% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 450.05 K | $63.18 M | 76.46% | 0.45% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/13/2025 | 411.66 K | $57.79 M | 228.90% | 0.42% |
| LEGAL & GENERAL GROUP PLC | 11/13/2025 | 400.17 K | $56.18 M | 0.19% | 0.40% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 10/20/2025 | 382.44 K | $52.39 M | -14.61% | 0.39% |
| UBS GROUP AG | 11/13/2025 | 364.57 K | $51.18 M | -39.45% | 0.37% |
| FIRST TRUST ADVISORS LP | 11/12/2025 | 363.11 K | $50.97 M | -14.25% | 0.37% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 353.64 K | $49.64 M | -19.36% | 0.36% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Neurocrine Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 894 institutional investors and hedge funds held shares of Neurocrine Biosciences, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 12.71 M
VANGUARD GROUP INC: 9.71 M
DODGE & COX: 5.56 M
JPMORGAN CHASE & CO: 4.73 M
STATE STREET CORP: 4.35 M
PRICE T ROWE ASSOCIATES INC /MD/: 2.87 M
98.02% of Neurocrine Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 138.01 M shares in the last 24 months. This purchase volume represents approximately $18.91 B in transactions.